<DOC>
	<DOCNO>NCT00915876</DOCNO>
	<brief_summary>This research study Vitamin D may affect blood vessel reaction stress blood level substance may increase blockage blood vessel chronic kidney disease ( CKD ) patient . Blood vessel health worsen CKD study show Vitamin D improve blood vessel health . The type Vitamin D use study ( paricalcitol ) Food Drug Administration ( FDA ) approve treat high parathyroid hormone level . The purpose study find paricalcitol benefit beyond ability lower parathyroid hormone level improve blood vessel reaction stress decrease blood level substance may increase blockage blood vessel .</brief_summary>
	<brief_title>Vascular Reactivity Chronic Kidney Disease ( CKD ) Patients Receiving Paricalcitol Versus Placebo</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<criteria>Males female â‰¥ 18 year age start screen CKD eGFR 1560 mL/min/1.73m2 MDRD Not expect start dialysis 4 month Serum intact PTH 70200 pg/mL screen period On stable ACEI/ARB regimen 30 day prior screen History follow disease : congestive heart failure MI within last 6 month history cerebrovascular accident significant valvular disease malignancy Currently take vitamin D product Mean systolic blood pressure value &gt; 190 diastolic blood pressure value &gt; 100 mm/Hg precede 30 day period prior screen Currently titrate therapy angiotensin convert enzyme inhibitor angiotensin receptor blocker Two consecutive serum calcium value great 10.2 mg/dL Ca x P &gt; 55 mg2/dL2 Currently receive erythropoiesis stimulate agent intravenous iron therapy Pregnant breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>chronic kidney disease</keyword>
	<keyword>Vitamin D</keyword>
</DOC>